122 related articles for article (PubMed ID: 26161406)
1. Interleukin 16- (IL-16-) Targeted Ultrasound Imaging Agent Improves Detection of Ovarian Tumors in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
Barua A; Yellapa A; Bahr JM; Adur MK; Utterback CW; Bitterman P; Basu S; Sharma S; Abramowicz JS
Biomed Res Int; 2015; 2015():567459. PubMed ID: 26161406
[TBL] [Abstract][Full Text] [Related]
2. VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
Ultrason Imaging; 2015 Jul; 37(3):224-37. PubMed ID: 25294846
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of Ovarian Tumor Detection by DR6-Targeted Ultrasound Imaging Agents in Laying Hen Model of Spontaneous Ovarian Cancer.
Barua A; Edassery SL; McNeal S; Bahr JM; Bitterman P; Basu S; Sharma S; Abramowicz JS
Int J Gynecol Cancer; 2016 Oct; 26(8):1375-85. PubMed ID: 27465898
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of ovarian tumor detection with αvβ3 integrin-targeted ultrasound molecular imaging agent in laying hens: a preclinical model of spontaneous ovarian cancer.
Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
Int J Gynecol Cancer; 2014 Jan; 24(1):19-28. PubMed ID: 24304684
[TBL] [Abstract][Full Text] [Related]
5. Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer.
Yellapa A; Bahr JM; Bitterman P; Abramowicz JS; Edassery SL; Penumatsa K; Basu S; Rotmensch J; Barua A
Int J Gynecol Cancer; 2012 Feb; 22(2):199-207. PubMed ID: 22274315
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 16 expression changes in association with ovarian malignant transformation.
Yellapa A; Bitterman P; Sharma S; Guirguis AS; Bahr JM; Basu S; Abramowicz JS; Barua A
Am J Obstet Gynecol; 2014 Mar; 210(3):272.e1-10. PubMed ID: 24380743
[TBL] [Abstract][Full Text] [Related]
7. Polycystic Ovarian Condition May Be a Risk Factor for Ovarian Tumor Development in the Laying Hen Model of Spontaneous Ovarian Cancer.
Lee HJ; Bahr JM; Bitterman P; Basu S; Sharma S; Abramowicz JS; Barua A
J Immunol Res; 2018; 2018():2590910. PubMed ID: 30596106
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Cancer: Applications of Chickens to Humans.
Barua A; Bahr JM
Annu Rev Anim Biosci; 2022 Feb; 10():241-257. PubMed ID: 35167319
[TBL] [Abstract][Full Text] [Related]
9. Glucose-Regulated Protein 78 Is a Potential Serum and Imaging Marker for Early Detection of Ovarian Cancer.
Paris EA; Bahr JM; Abramowicz JS; Basu S; Barua A
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831486
[TBL] [Abstract][Full Text] [Related]
10. Detection of tumor-associated neoangiogenesis by Doppler ultrasonography during early-stage ovarian cancer in laying hens: a preclinical model of human spontaneous ovarian cancer.
Barua A; Bitterman P; Bahr JM; Bradaric MJ; Hales DB; Luborsky JL; Abramowicz JS
J Ultrasound Med; 2010 Feb; 29(2):173-82. PubMed ID: 20103787
[TBL] [Abstract][Full Text] [Related]
11. Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer.
Paris EA; Bahr JM; Bitterman P; Basu S; Abramowicz JS; Barua A
PLoS One; 2021; 16(7):e0255007. PubMed ID: 34314463
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced sonography depicts spontaneous ovarian cancer at early stages in a preclinical animal model.
Barua A; Bitterman P; Bahr JM; Basu S; Sheiner E; Bradaric MJ; Hales DB; Luborsky JL; Abramowicz JS
J Ultrasound Med; 2011 Mar; 30(3):333-45. PubMed ID: 21357555
[TBL] [Abstract][Full Text] [Related]
13. Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer.
Barua A; Yellapa A; Bahr JM; Abramowicz JS; Edassery SL; Basu S; Rotmensch J; Bitterman P
Transl Oncol; 2012 Aug; 5(4):260-8. PubMed ID: 22937178
[TBL] [Abstract][Full Text] [Related]
14. Expression of Leukocyte Inhibitory Immunoglobulin-like Transcript 3 Receptors by Ovarian Tumors in Laying Hen Model of Spontaneous Ovarian Cancer.
Khan MF; Bahr JM; Yellapa A; Bitterman P; Abramowicz JS; Edassery SL; Basu S; Rotmensch J; Barua A
Transl Oncol; 2012 Apr; 5(2):85-91. PubMed ID: 22496924
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer.
Barua A; Bitterman P; Abramowicz JS; Dirks AL; Bahr JM; Hales DB; Bradaric MJ; Edassery SL; Rotmensch J; Luborsky JL
Int J Gynecol Cancer; 2009 May; 19(4):531-9. PubMed ID: 19509547
[TBL] [Abstract][Full Text] [Related]
16. Association of Immunosuppression with DR6 Expression during the Development and Progression of Spontaneous Ovarian Cancer in Laying Hen Model.
McNeal S; Bitterman P; Bahr JM; Edassery SL; Abramowicz JS; Basu S; Barua A
J Immunol Res; 2016; 2016():6729379. PubMed ID: 27579331
[TBL] [Abstract][Full Text] [Related]
17. Dietary supplementation of Ashwagandha (Withania somnifera, Dunal) enhances NK cell function in ovarian tumors in the laying hen model of spontaneous ovarian cancer.
Barua A; Bradaric MJ; Bitterman P; Abramowicz JS; Sharma S; Basu S; Lopez H; Bahr JM
Am J Reprod Immunol; 2013 Dec; 70(6):538-50. PubMed ID: 24188693
[TBL] [Abstract][Full Text] [Related]
18. Detection of ovarian tumors in chicken by sonography: a step toward early diagnosis in humans?
Barua A; Abramowicz JS; Bahr JM; Bitterman P; Dirks A; Holub KA; Sheiner E; Bradaric MJ; Edassery SL; Luborsky JL
J Ultrasound Med; 2007 Jul; 26(7):909-19. PubMed ID: 17592054
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.
Lutz AM; Bachawal SV; Drescher CW; Pysz MA; Willmann JK; Gambhir SS
Clin Cancer Res; 2014 Mar; 20(5):1313-22. PubMed ID: 24389327
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention.
Rodríguez-Burford C; Barnes MN; Berry W; Partridge EE; Grizzle WE
Gynecol Oncol; 2001 Jun; 81(3):373-9. PubMed ID: 11371125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
